Sabra Health Care REIT Stock Forecast
NASDAQ: SBRAReal EstateReal Estate Investment TrustsUSD
Market open · Delayed 15 min · as of Oct 9, 3:57 PM ET
SBRA analyst consensus
Consensus (16 analysts)
buy
Avg. price target
$22.79+20.11%
- Strong buy 1
- Buy 5
- Hold 10
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 16 Wall Street analysts covering Sabra Health Care REIT (2026-10-08), 6 rate the stock a buy or strong buy, 10 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "buy". The average 12-month price target is $22.79, with a high estimate of $25.00 and a low estimate of $19.00. The average target implies upside of 20.1% from the current price of $18.98.
The spread between the highest and lowest targets is 31.6%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for SBRA.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 6% |
| Buy | 5 | 31% |
| Hold | 10 | 63% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-10-08.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $19.00 | +0.13% |
| Average target | $22.79 | +20.11% |
| High target | $25.00 | +31.75% |